Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice.
D000328:Adult; D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001770:Blood Bactericidal Activity; D002177:Candidiasis / Q000209:etiology; D002465:Cell Movement; D002609:Chediak-Higashi Syndrome / Q000188:drug therapy*; D002634:Chemotaxis, Leukocyte; D000242:Cyclic AMP / Q000097:blood; D006152:Cyclic GMP / Q000097:blood; D006801:Humans; D007962:Leukocytes / Q000502:physiology; D008213:Lymphocyte Activation; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009504:Neutrophils / Q000201:enzymology
D000242:Cyclic AMP; D006152:Cyclic GMP; D001205:Ascorbic Acid